These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8671855)

  • 1. Frequency of adynamic bone disease and aluminum storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies.
    Ballanti P; Wedard BM; Bonucci E
    Nephrol Dial Transplant; 1996 Apr; 11(4):663-7. PubMed ID: 8671855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aluminum and uremic bone disease. Diagnostic utility of serum aluminum and the deferoxamine (DFO) test ].
    Jarava C; Armas JR; Palma A
    Nefrologia; 2001; 21(2):174-81. PubMed ID: 11464651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of adynamic bone disease in dialyzed patients.
    Malluche HH; Monier-Faugere MC
    Kidney Int Suppl; 1992 Oct; 38():S62-7. PubMed ID: 1405383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adynamic bone disease in patients with uremia.
    Fournier A; Yverneau PH; Hué P; Said S; Hamdini N; Eldin HM; Mohageb S; Oprisiu R; Marie A; Solal ME
    Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):396-410. PubMed ID: 8076143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aluminum in renal osteodystrophy].
    Zhu P; Wang GY; Yu YF; Zhu P
    Zhonghua Nei Ke Za Zhi; 1993 Mar; 32(3):176-8. PubMed ID: 8222983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histomorphometric assessment of bone turnover in uraemic patients: comparison between activation frequency and bone formation rate.
    Ballanti P; Coen G; Mazzaferro S; Taggi F; Giustini M; Calabria S; Ferrannini M; Bonucci E
    Histopathology; 2001 Jun; 38(6):571-83. PubMed ID: 11422502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low turnover bone disease is the more common form of bone disease in CAPD patients.
    Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L
    Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological, radiological, and biochemical features of the adynamic bone lesion in continuous ambulatory peritoneal dialysis patients.
    Hutchison AJ; Whitehouse RW; Freemont AJ; Adams JE; Mawer EB; Gokal R
    Am J Nephrol; 1994; 14(1):19-29. PubMed ID: 8017477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis.
    Hernandez D; Concepcion MT; Lorenzo V; Martinez ME; Rodriguez A; De Bonis E; Gonzalez-Posada JM; Felsenfeld AJ; Rodriguez M; Torres A
    Nephrol Dial Transplant; 1994; 9(5):517-23. PubMed ID: 7522307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adynamic bone and chronic renal failure: an overview.
    Cannata Andía JB
    Am J Med Sci; 2000 Aug; 320(2):81-4. PubMed ID: 10981480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow aluminium storage in renal failure.
    Kaye M
    J Clin Pathol; 1983 Nov; 36(11):1288-91. PubMed ID: 6630578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-aluminic adynamic bone disease in non-dialyzed uremic patients: a new type of osteopathy due to overtreatment?
    Cohen-Solal ME; Sebert JL; Boudailliez B; Westeel PF; Morinière PH; Marie A; Garabedian M; Fournier A
    Bone; 1992; 13(1):1-5. PubMed ID: 1581102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide].
    Belbrik S; Marie A; Boudailliez B; Morinière P; Sébert JL; Solal MC; Westeel PF; Roche D; Fournier A
    Nephrologie; 1990; 11(2):83-90. PubMed ID: 2392208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron overload and bone disease in chronic dialysis patients.
    Van de Vyver FL; Visser WJ; D'Haese PC; De Broe ME
    Nephrol Dial Transplant; 1990; 5(9):781-7. PubMed ID: 2129351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption.
    Heaf JG; Pødenphant J; Andersen JR
    Nephron; 1986; 42(3):210-6. PubMed ID: 3945361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of strontium on bone metabolism in hemodialysis patients].
    Gerstenfeld S; Hinojosa L; Serrano Arias M; Menéndez Rodríguez P; Fernández Martín JL; Marchante JM; García Alonso JI; Sanz-Medel A; Cannata Andía JB
    Nefrologia; 2003; 23 Suppl 2():52-6. PubMed ID: 12778855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis.
    Gerakis A; Hutchison AJ; Apostolou T; Freemont AJ; Billis A
    Nephrol Dial Transplant; 1996 Dec; 11(12):2430-8. PubMed ID: 9017618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of iron bone deposits in a Mexican population with renal osteodystrophy.
    Velásquez Forero F; Altamirano E; Ramos PT
    Nephrol Dial Transplant; 1998; 13 Suppl 3():46-50. PubMed ID: 9568820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for renal osteodystrophy: a multivariant analysis.
    Pei Y; Hercz G; Greenwood C; Segre G; Manuel A; Saiphoo C; Fenton S; Sherrard D
    J Bone Miner Res; 1995 Jan; 10(1):149-56. PubMed ID: 7747622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.